Current and Future Therapeutic Options in Pain Management: Multi-mechanistic Opioids Involving Both MOR and NOP Receptor Activation-Reference-Cited by-同舟云学术

Current and Future Therapeutic Options in Pain Management: Multi-mechanistic Opioids Involving Both MOR and NOP Receptor Activation

Published:2022-05-26 Issue:6 Volume:36 Page:617-632
ISSN:1172-7047
Container-title:CNS Drugs
language:en
Short-container-title:CNS Drugs

Author:

Coluzzi Flaminia^ORCID,Rullo Laura^ORCID,Scerpa Maria Sole^ORCID,Losapio Loredana Maria^ORCID,Rocco Monica^ORCID,Billeci Domenico^ORCID,Candeletti Sanzio^ORCID,Romualdi Patrizia^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Psychiatry and Mental health,Neurology (clinical)

Link

https://link.springer.com/content/pdf/10.1007/s40263-022-00924-2.pdf

Reference118 articles.

1. Treede R-D, Rief W, Barke A, Aziz Q, Bennett MI, Benoliel R, et al. Chronic pain as a symptom or a disease: the IASP classification of chronic pain for the International Classification of Diseases (ICD-11). Pain. 2019;160:19–27. https://doi.org/10.1097/j.pain.0000000000001384.

2. Cohen SP, Vase L, Hooten WM. Chronic pain: an update on burden, best practices, and new advances. Lancet. 2021;397:2082–97. https://doi.org/10.1016/S0140-6736(21)00393-7.

3. Caraceni A, Hanks G, Kaasa S, Bennett MI, Brunelli C, Cherny N, et al. Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol. 2012;13:e58-68. https://doi.org/10.1016/S1470-2045(12)70040-2.

4. Ambrosio F, Finco G, Mattia C, Mediati R, Paoletti F, Coluzzi F, et al. SIAARTI recommendations for chronic noncancer pain. Minerva Anestesiol. 2006;72:859–80.

5. Coluzzi F, Alvaro D, Caraceni AT, Gianni W, Marinangeli F, Massazza G, et al. Common clinical practice for opioid-induced constipation: a physician survey. J Pain Res. 2021;14:2255–64. https://doi.org/10.2147/JPR.S318564.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cannabinoid CB2 receptors in primary sensory neurons are implicated in CB2 agonist-mediated suppression of paclitaxel-induced neuropathic nociception and sexually-dimorphic sparing of morphine tolerance;Biomedicine & Pharmacotherapy;2024-07

2. Discovery of ITI-333, a Novel Orally Bioavailable Molecule Targeting Multiple Receptors for the Treatment of Pain and Other Disorders;Journal of Medicinal Chemistry;2024-05-28

3. Neuropsychiatric Effects Associated with Opioid-Based Management for Palliative Care Patients;Current Pain and Headache Reports;2024-04-02

4. Analgesic Peptides: From Natural Diversity to Rational Design;Molecules;2024-03-29

5. Cannabinoid CB₂receptors in primary sensory neurons are implicated in CB₂agonist-mediated suppression of paclitaxel-induced neuropathic nociception and sexually-dimorphic sparing of morphine tolerance;2024-03-10